Considering our results demonstrating the neuromodulatory action of betaine via GAT1, it is possible that in neurodegenerative diseases that cause loss of neurons, like AD and PD, betaine could benefit not only by protecting the CNS against oxidative stress, but also by regulating GABA levels to maintain the E/I balance. Here, SLC6A1 is linked to Parkinson disease.